Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, Viatris
WeightWatchers to offer compounded version of Novo Nordisk's weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of its weight-management programs, sending its shares nearly 47% higher to an over two-month closing high.
Novo Nordisk (NYSE:NVO) and Viatris Settle Patent Dispute for Weight-Loss Drugs
Novo Nordisk ($NVO) and Viatris ($VTRS) have agreed to settle a dispute over patents for Novo’s weight-loss drugs, Ozempic and Wegovy, according
Novo Nordisk, Viatris settle patent dispute over Ozempic, Wegovy: report
Novo Nordisk (NVO) and Viatris (NASDAQ:VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo’s popular weight-loss drugs Wegovy and Ozempic. The companies announced the settlement in a joint filing on Friday made with the U.
7h
on MSN
WeightWatchers Is Offering Knockoff Wegovy. The Market Is Already Crowded.
The compounding pharmacies that supply knockoff Wegovy can only legally make it as long as it remains on the Food and Drug ...
FiercePharma
1d
Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case
With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...
6h
WeightWatchers to offer compounded version of Wegovy weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
devdiscourse
1h
WeightWatchers Launches Compounded Novo Nordisk Drug Amid Health Innovations
Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...
1d
Novo Nordisk settles US patent fight with Viatris over Ozempic
Novo Nordisk and Viatris have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...
USA Today
14d
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
Senators grilled the top executive of
Novo
Nordisk over why the Danish company charges Americans far more for the blockbuster weight-loss drug
Wegovy
and diabetes drug Ozempic than it does ...
6d
on MSN
Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...
Benefits Pro
13d
'Stop ripping us off,' says Sen. Sanders, but Novo CEO blames PBMs for high Wegovy prices
Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...
14d
Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices
The CEO of Novo Nordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday, as lawmakers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Weight Watchers
Ozempic
Feedback